TekniPlex Healthcare to Showcase Capabilities Enabling the Next Generation of Medical Device Solutio
Company to highlight integrated capabilities spanning custom material formulations, precision extrusion, catheter construction and finished-device assembly.
Wayne, PA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- TekniPlex Healthcare will showcase its comprehensive materials science, precision extrusion and interventional-device manufacturing capabilities at MD&M Midwest 2026, taking place October 28–29 at the Minneapolis Convention Center.
At Booth 3903, the company will highlight its ability to help medical device OEMs address complex design and manufacturing challenges while supporting the development of next-generation medical devices.
TekniPlex Healthcare's exhibit will demonstrate its integrated capabilities across the medical device development and manufacturing process, from custom material and formulations to precision-extruded tubing, catheter components and finished devices.
Together, these stages reflect the company's three areas of focus:
- Materials and formulation expertise: Custom compounds and specialized material formulations tailored to medical device applications and performance requirements.
- Precision tubing and catheter construction: Advanced extrusion capabilities encompassing single- and multi-lumen tubing, extruded jackets, braided shafts and catheter-building capabilities.
- Components and assemblies: Precision-molded components and finished-device assembly capabilities, supported by applicable manufacturing technologies and site-specific expertise.
These capabilities enable medical device OEMs to navigate critical decisions throughout the product development cycle.
The company will also emphasize its ability to support customers in evaluating material and component selections early in development, optimizing interventional device designs for manufacturability, and addressing process, quality, qualification and supply considerations as products advance towards commercial production.
"Device teams are being asked to support new care settings and more demanding therapies while moving faster to market,” said John Zawacki, Senior Director of Strategic Marketing, TekniPlex Healthcare. “By bringing materials science, precision tubing and catheter building together, we help our customers make better decisions earlier and support a smoother path from concept to validated production. MD&M Midwest is a great place to start those conversations."
Through its combination of materials expertise, precision manufacturing technologies and device assembly capabilities, TekniPlex Healthcare continues to support medical device OEMs in developing innovative solutions that meet evolving clinical needs and increasingly complex manufacturing requirements.
###
About TekniPlex Healthcare
TekniPlex Healthcare utilizes advanced materials science expertise and technologies to develop and deliver critical solutions for medical and diagnostic devices, drug delivery systems and sterile barrier healthcare packaging applications. With a global reach, the division's deep understanding of the greater pharmaceuticals and medical landscape helps it produce exemplary barrier properties for drugs and precision medical devices for interventional and therapeutic procedures.
For medical device OEMs, TekniPlex Healthcare embodies a comprehensive CDMO partner capable of servicing every stage of the product life cycle, from design and development through component manufacturing and final assembly. Throughout its broad purview, the division's ever-evolving portfolio helps meet demands for high-leverage medicines and mission-critical healthcare products that benefit care providers and patients. For more information visit www.tekni-plex.com/healthcare.
Contact Info
Natalia Rivera
natalia.rivera@tekni-plex.com
+1 480-395-3130
- “ 乐乐趣智趣阅读 ”AI产品 科技赋能儿童阅读体验
- 十年陪伴,2亿选择:必胜客会员十周年,宠粉全面加码
- 广州大学城科技园:为何是企业入驻的理想之地?
- 九识无人车陕西运营中心展厅启幕 打造智能城配物流新标杆
- 晨光公益基金会携手深圳壹基金 紧急驰援广西南宁防汛救灾
- 税务透明化下,深圳企业家为何首选侨置移民办理多米尼克护照?
- Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to t
- Iveco Group announces the results of the Annual General Meeting
- 阿那亚礼堂光影秀点亮戏剧节之夜:数字艺术解码文旅商业新叙事
- Stryker and CMR Surgical announce strategic alliance to advance robotic-assisted surgery
- 韩林子Ⅱ人类概论(21---30)
- 龙樾海序,凭什么能走出市场独立行情?
- 为短剧观众服务——看听花岛“以观众为中心”的创作方法论
- 暖心姐姐凯丽再度上线 《花少好友记》惊喜频出感动不断
- 极豪科技赴港IPO:卡位物理AI时代的「交互基座」稀缺性锚定估值新坐标
- 2025法保网品牌战略全新升级:构筑 G-B-C全场景AI法律科技新生态
- 漫步北京小程序+气象景观数字化服务平台,让气象景观触手可及
- 聚势共生 商赢未来|淘聚商盟盛大开业共启商业新征程
- 甜心皮皮昆明品鉴会燃爆全场,二店同步开业续写火爆传奇
- GEO营销成品牌增长新引擎 慧辰股份发布ImpetaAI助力企业抢占AI认知高地
- Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW171 in Advanced Mesot
- 古韵雄州展新篇,政策沃土育英才——雄县“雄创杯”邀您共赴创新创业新征程
- Neat 推出 Thinking Rooms,具备 Agentic Deployment Management 和 Intelligent Framing 功能
- 展讯 | 寻源——薛磊、文永生、黄胜凡作品展
- Mohawk Industries Reports Q1 Results
- 下一个全球 AI 趋势有了“脸”:Kindred Labs 与 IPX(LINE FRIENDS、BT21)达成合作,将角色变成日常 AI
- 晓芹海参2025经销商大会召开,小马宋等现场赋能
- 从“营销员”到“创享家”:开启事业与生活新赛道——中荷人寿发布“中荷创享家”代理人品牌
- 双靶头对头:信达生物全球首创抗VEGF-补体双靶融合蛋白依莫芙普(IBI302)治疗糖尿病黄斑水肿的II期临床研究完成首例受试者给药
- 告别反光、拖影与平配音效!追觅AI电视V3000的Aura Mini LED+AI功能藏在这





